Relative bradycardia in patients with septic shock requiring vasopressor therapy

Critical Care Medicine

Volumn 45, Issue 2, 2017, Pages 225-233

  Beesley, Sarah J ^a,b   Wilson, Emily L ^a   Lanspa, Michael J ^a,b   Grissom, Colin K ^a,b   Shahul, Sajid ^c   Talmor, Daniel ^d   Brown, Samuel M ^a,b  

^a INTERMOUNTAIN MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

bradycardia; septic shock; vasopressor therapy

Indexed keywords

DOBUTAMINE; EPINEPHRINE; HEMOGLOBIN; HYPERTENSIVE FACTOR; MILRINONE; NORADRENALIN; PHENYLEPHRINE; VASOCONSTRICTOR AGENT;

ADULT; AGED; APACHE; ARTICLE; ARTIFICIAL VENTILATION; ATRIAL FIBRILLATION; BRADYCARDIA; CHRONIC ATRIAL FIBRILLATION; CLINICAL OUTCOME; COMMUNITY HOSPITAL; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; EQUIPOISE; FEMALE; FLUID RESUSCITATION; HUMAN; HYPOTHYROIDISM; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; PRIORITY JOURNAL; QRS INTERVAL; RETROSPECTIVE STUDY; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SURVIVAL; UNIVERSITY HOSPITAL; COMPLICATION; HEART RATE; MIDDLE AGED; PROPENSITY SCORE; RISK FACTOR; SHOCK, SEPTIC; STATISTICAL MODEL;

AGED; BRADYCARDIA; FEMALE; HEART RATE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROPENSITY SCORE; RETROSPECTIVE STUDIES; RISK FACTORS; SHOCK, SEPTIC; VASOCONSTRICTOR AGENTS;

EID: 84987602279     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000002065     Document Type: Article

References (44)

1. Dombrovskiy VY, Martin AA, Sunderram J, et al. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003. Crit Care Med 2007; 35: 1244-1250
2. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315: 801-810
3. Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med 2006; 34: 344-353
4. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013; 39: 165-228
5. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med 2013; 369: 840-851
6. Goldenberg NM, Steinberg BE, Slutsky AS, et al. Broken barriers: A new take on sepsis pathogenesis. Sci Transl Med 2011; 3: 88ps25
7. Galley HF. Oxidative stress and mitochondrial dysfunction in sepsis. Br J Anaesth 2011; 107: 57-64
8. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005; 365: 63-78
9. Parrillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med 1993; 328: 1471-1477
10. Huston JM, Tracey KJ. The pulse of inflammation: Heart rate variability, the cholinergic anti-inflammatory pathway and implications for therapy. J Intern Med 2011; 269: 45-53
11. Brown SM, Pittman JE, Hirshberg EL, et al. Diastolic dysfunction and mortality in early severe sepsis and septic shock: A prospective, observational echocardiography study. Crit Ultrasound J 2012; 4: 8
12. Rudiger A, Singer M. The heart in sepsis: From basic mechanisms to clinical management. Curr Vasc Pharmacol 2013; 11: 187-195
13. Annane D, Trabold F, Sharshar T, et al. Inappropriate sympathetic activation at onset of septic shock: A spectral analysis approach. Am J Respir Crit Care Med 1999; 160: 458-465
14. Chen WL, Chen JH, Huang CC, et al. Heart rate variability measures as predictors of in-hospital mortality in ED patients with sepsis. Am J Emerg Med 2008; 26: 395-401
15. Wollmann CG, Gradaus R, Böcker D, et al. Variations of heart rate variability parameters prior to the onset of ventricular tachyarrhythmia and sinus tachycardia in ICD patients. Results from the heart rate variability analysis with automated ICDs (HAWAI) registry. Physiol Meas 2015; 36: 1047-1061
16. Parker MM, Shelhamer JH, Natanson C, et al. Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: Heart rate as an early predictor of prognosis. Crit Care Med 1987; 15: 923-929
17. Kumar A, Schupp E, Bunnell E, et al. Cardiovascular response to dobutamine stress predicts outcome in severe sepsis and septic shock. Crit Care 2008; 12: R35
18. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup: Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41: 580-637
19. Spodick DH. Normal sinus heart rate: Appropriate rate thresholds for sinus tachycardia and bradycardia. South Med J 1996; 89: 666-667
20. Miller RR 3rd, Dong L, Nelson NC, et al. Intermountain Healthcare Intensive Medicine Clinical Program: Multicenter implementation of a severe sepsis and septic shock treatment bundle. Am J Respir Crit Care Med 2013; 188: 77-82
21. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644-1655
22. Brown SM, Lanspa MJ, Jones JP, et al. Survival after shock requiring high-dose vasopressor therapy. Chest 2013; 143: 664-671
23. Knox DB, Lanspa MJ, Kuttler KG, et al. Phenotypic clusters within sepsis-Associated multiple organ dysfunction syndrome. Intensive Care Med 2015; 41: 814-822
24. Leligdowicz A, Dodek PM, Norena M, et al. Co-operative Antimicrobial Therapy of Septic Shock Database Research Group: Association between source of infection and hospital mortality in patients who have septic shock. Am J Respir Crit Care Med 2014; 189: 1204-1213
25. Knaus WA, Draper EA, Wagner DP, et al. APACHE II A severity of disease classification system. Crit Care Med 1985; 13: 818-829
26. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22: 707-710
27. Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care 1998; 36: 8-27
28. Pine M, Jordan HS, Elixhauser A, et al. Enhancement of claims data to improve risk adjustment of hospital mortality. JAMA 2007; 297: 71-76
29. Moreno R, Vincent JL, Matos R, et al. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis related Problems of the ESICM. Intensive Care Med 1999; 25: 686-696
30. Robins JM, Hernán MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology 2000; 11: 550-560
31. Hernán MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology 2000; 11: 561-570
32. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995; 57: 289-300
33. R Development Core Team: R A Language and Environment for Statistical Computing. Vienna, Austria, R Foundation for Statistical Computing, 2014
34. Azimi G, Vincent JL. Ultimate survival from septic shock. Resuscitation 1986; 14: 245-253
35. Magder SA. The ups and downs of heart rate. Crit Care Med 2012; 40: 239-245
36. Santana JS, Franco Filho JC, Sá Neto AA, et al. Prognostic value of chronotropic incompetence in elderly patients undergoing exercise echocardiography. Arq Bras Cardiol 2013; 100: 429-436
37. Gore DC, Wolfe RR. Hemodynamic and metabolic effects of selective beta1 adrenergic blockade during sepsis. Surgery 2006; 139: 686-694
38. Balik M, Rulisek J, Leden P, et al. Concomitant use of beta-1 adrenoreceptor blocker and norepinephrine in patients with septic shock. Wien Klin Wochenschr 2012; 124: 552-556
39. Schmittinger CA, Dünser MW, Haller M, et al. Combined milrinone and enteral metoprolol therapy in patients with septic myocardial depression. Crit Care 2008; 12: R99
40. Morelli A, Ertmer C, Westphal M, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: A randomized clinical trial. JAMA 2013; 310: 1683-1691
41. Ackland GL, Yao ST, Rudiger A, et al. Cardioprotection, attenuated systemic inflammation, and survival benefit of beta1-Adrenoceptor blockade in severe sepsis in rats. Crit Care Med 2010; 38: 388-394
42. Hayes MA, Timmins AC, Yau EH, et al. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994; 330: 1717-1722
43. Alía I, Esteban A, Gordo F, et al A randomized and controlled trial of the effect of treatment aimed at maximizing oxygen delivery in patients with severe sepsis or septic shock. Chest 1999; 115: 453-461
44. Macchia A, Romero M, Comignani PD, et al. Previous prescription of β-blockers is associated with reduced mortality among patients hospitalized in intensive care units for sepsis. Crit Care Med 2012; 40: 2768-2772